129 related articles for article (PubMed ID: 22348365)
41. Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.
Fu EL; van Diepen M
Diabetes Care; 2020 Nov; 43(11):e190. PubMed ID: 33082247
[No Abstract] [Full Text] [Related]
42. [Glucose lowering drugs in case of impaired renal function].
Assink MA; Abrahams AC; Rookmaaker MB
Ned Tijdschr Geneeskd; 2014; 158():A6907. PubMed ID: 24618238
[TBL] [Abstract][Full Text] [Related]
43. Response to Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.
Kwon S; Kim CT; Lee JP
Diabetes Care; 2020 Nov; 43(11):e191. PubMed ID: 33082248
[No Abstract] [Full Text] [Related]
44. Management of glycemia in diabetic patients with diabetic kidney disease.
Liu F; Fu P
Chin Med J (Engl); 2014; 127(6):1170-6. PubMed ID: 24622454
[No Abstract] [Full Text] [Related]
45. [Recommendations for the drug therapy of diabetes type 2. Treatment of associated vascular risk factors. French Agency for the Safety of Therapeutic Products].
Presse Med; 1999 Oct; 28(29):1584-9. PubMed ID: 10544712
[No Abstract] [Full Text] [Related]
46. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies.
Chang W; Chen L; Hatch GM
Biochem Cell Biol; 2015 Oct; 93(5):479-86. PubMed ID: 25607236
[TBL] [Abstract][Full Text] [Related]
47. Antidiabetic medications and polypharmacy.
Peron EP; Ogbonna KC; Donohoe KL
Clin Geriatr Med; 2015 Feb; 31(1):17-27, vii. PubMed ID: 25453298
[TBL] [Abstract][Full Text] [Related]
48. [Rational hypoglycemic therapy - nephro-diabetologic view].
Kosmalski M; Kurnatowska I
Pol Merkur Lekarski; 2018 Aug; 45(266):81-88. PubMed ID: 30240375
[TBL] [Abstract][Full Text] [Related]
49. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update.
Aperis G
J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390
[No Abstract] [Full Text] [Related]
50. Pleiotropic effects of anti-diabetic drugs: A comprehensive review.
Nath M; Bhattacharjee K; Choudhury Y
Eur J Pharmacol; 2020 Oct; 884():173349. PubMed ID: 32650008
[TBL] [Abstract][Full Text] [Related]
51. Emerging Targets in Type 2 Diabetes and Diabetic Complications.
Demir S; Nawroth PP; Herzig S; Ekim Üstünel B
Adv Sci (Weinh); 2021 Sep; 8(18):e2100275. PubMed ID: 34319011
[TBL] [Abstract][Full Text] [Related]
52. [Use of new antidiabetics in the elderly population].
Besse S; Besse A; Jornayvaz FR
Rev Med Suisse; 2016 Jun; 12(521):1101-6. PubMed ID: 27487679
[TBL] [Abstract][Full Text] [Related]
53. Second-Line Agents for the Treatment of Type 2 Diabetes and Prevention of CKD.
Yu MK; Kim SH
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2104-2106. PubMed ID: 27827307
[No Abstract] [Full Text] [Related]
54. Urogenital infections in patients with diabetes mellitus: Beyond the conventional aspects.
La Vignera S; Condorelli RA; Cannarella R; Giacone F; Mongioi' LM; Cimino L; Defeudis G; Mazzilli R; Calogero AE
Int J Immunopathol Pharmacol; 2019; 33():2058738419866582. PubMed ID: 32031031
[TBL] [Abstract][Full Text] [Related]
55. Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives.
de Vries JK; Levin A; Loud F; Adler A; Mayer G; Pena MJ
Diabetes Obes Metab; 2018 Oct; 20 Suppl 3(Suppl Suppl 3):24-29. PubMed ID: 30294955
[TBL] [Abstract][Full Text] [Related]
56. CYSTATIN C, DIABETIC KIDNEY DISEASE, AND IMPLICATIONS FOR DIABETES MANAGEMENT.
Nadolsky KZ
Endocr Pract; 2017 Feb; 23(2):241-242. PubMed ID: 27849381
[No Abstract] [Full Text] [Related]
57. Preoperative Patient Evaluation: Newer Hypoglycemic Agents.
Villasenor M; Selzer AR
Anesthesiol Clin; 2024 Mar; 42(1):41-52. PubMed ID: 38278591
[TBL] [Abstract][Full Text] [Related]
58. Meta-Analysis on the Efficacy of Novel Glucose-Lowering Agents in Older Patients With Type 2 Diabetes Mellitus.
Ahmed A; Imran L; Naeem U; Jawed A; Jawed A; Khan Z; Arshad AR; Arshad MS
Am J Cardiol; 2023 Jan; 187():127-130. PubMed ID: 36459735
[No Abstract] [Full Text] [Related]
59. Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.
Amin M; Suksomboon N
Drug Saf; 2014 Nov; 37(11):903-19. PubMed ID: 25249046
[TBL] [Abstract][Full Text] [Related]
60. [Diagram of diagnosis and management of type 2 diabetes mellitus. Update].
Názara Otero CA; Pose Reino A
Hipertens Riesgo Vasc; 2016; 33(1):38-40. PubMed ID: 26684254
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
